- 全部删除
您的购物车当前为空
SRI 37892是一种 Fzd7抑制剂,对 Wnt/β-catenin 信号传导和癌症细胞活性具有强大的活性。


为众多的药物研发团队赋能,
让新药发现更简单!
SRI 37892是一种 Fzd7抑制剂,对 Wnt/β-catenin 信号传导和癌症细胞活性具有强大的活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,960 | In stock | |
| 5 mg | ¥ 6,860 | In stock | |
| 10 mg | ¥ 9,430 | In stock | |
| 25 mg | ¥ 13,800 | In stock | |
| 50 mg | ¥ 18,900 | In stock | |
| 100 mg | ¥ 25,500 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 7,630 | In stock |
SRI 37892 相关产品
| 产品描述 | SRI 37892 is a Fzd7 inhibitor with potent activities against Wnt/β-catenin signaling and cancer cell viability. |
| 体外活性 | SRI37892 block Wnt/β-catenin signaling in HEK293 cells induced by Wnt3A and LRP6 with IC50 of 0.66 μM and 0.78 μM, respectively[1]. |
| 分子量 | 465.53 |
| 分子式 | C26H19N5O2S |
| CAS No. | 1030769-75-5 |
| Smiles | C(NC1=NC(=CS1)C=2C=C3C(=CC2)NC(=O)CC3)(=O)C4=CC=C(N5C=6C(N=C5)=CC=CC6)C=C4 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (107.4 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容